Загрузка...
Quantitative risk-benefit analysis of natalizumab
OBJECTIVE: To model the long-term risks and benefits of natalizumab in individuals with relapsing multiple sclerosis (MS). METHODS: We created a Markov model to evaluate treatment effects on reducing relapses and slowing disease progression using published natural history data and clinical trial res...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Academy of Neurology
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2676947/ https://ncbi.nlm.nih.gov/pubmed/18663181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000319648.65173.7a |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|